Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+16.3%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+16.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 79.60% |
| 2023 | 47.69% |
| 2022 | -11.19% |
| 2021 | 50.65% |
| 2020 | 32.16% |
| 2019 | -8.09% |
| 2018 | -22.17% |
| 2017 | -61.00% |
| 2016 | 0.00% |